Georgia officials halted all in-state poultry sales, and the U.S. Department of Health and Human Services awarded $590 ...
Bird flu has been detected in a commercial poultry flock in Georgia for the first time since the current outbreak began in ...
The current public-health risk is low, but the CDC is watching the situation carefully and working with states to monitor ...
Meanwhile, there is no approved vaccine for bird flu in humans, although the national stockpile includes certain shots developed in the past and tested on volunteers. That's because there haven't been ...
In terms of liquidity and interest, the mean open interest for Moderna options trades today is 1878.47 with a total volume of ...
Annemarie Hanekamp has overseen some of the most transformative changes in oncology over her years in Big Pharma. Now, she ...
Moderna (NASDAQ: MRNA) shareholders have been having a rough time lately. The biotech stock rocketed higher last spring, but ...
Morgan Stanley analyst Terence Flynn lowered the firm’s price target on Moderna (MRNA) to $38 from $70 and keeps an Equal Weight rating on the ...
Moderna provided updates on key elements of its pipeline, including a next-generation COVID-19 vaccine, an RSV vaccine, a new ...
J.P. Morgan analyst Jessica Fye has maintained their bearish stance on MRNA stock, giving a Sell rating yesterday.Stay Ahead of the ...
Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business, largely due ...
Stéphane Bancel, CEO of mRNA specialist Moderna, delivered some difficult truths to shareholders about the company’s ...